New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma

An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is currently critical for improving the prognosis and reducing the associated economic burden. Alpha-fetoprotein (AFP) is the most widely used biomarker for HCC diagnosis. Based on elevated serum AFP levels as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Zhang, Kun-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456927/
https://www.ncbi.nlm.nih.gov/pubmed/32923383
http://dx.doi.org/10.3389/fonc.2020.01316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456927/
https://www.ncbi.nlm.nih.gov/pubmed/32923383
http://dx.doi.org/10.3389/fonc.2020.01316

Ejemplares similares